FDA awards humanitarian status to Exalenz's liver diagnostic tool

09/11/2011 | Globes (Israel)

Exalenz Bioscience has secured humanitarian device exemption status from the FDA for its BreathID device in the diagnosis of acute liver failure, shortening its process to FDA approval. The designation comes a week after the company received FDA approval for a clinical study designed to evaluate the efficacy of the device in detecting liver cancer at an early stage.

View Full Article in:

Globes (Israel)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel, Regulatory FDA
Cardinal Health
Columbus, OH
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA